CLINICAL TRIALS PROFILE FOR ANDROID 10
✉ Email this page to a colleague
All Clinical Trials for Android 10
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02107014 ↗ | Low Dose Naltrexone (LDN) Immune Monitoring | Completed | Stanford University | N/A | 2014-03-01 | We have found that low dose naltrexone (LDN) can substantially reduce pain associated with fibromyalgia syndrome. We believe LDN may work via novel anti-inflammatory channels. The purpose of this study is to determine if LDN lowers inflammatory markers in individuals with fibromyalgia. |
NCT02107014 ↗ | Low Dose Naltrexone (LDN) Immune Monitoring | Completed | University of Alabama at Birmingham | N/A | 2014-03-01 | We have found that low dose naltrexone (LDN) can substantially reduce pain associated with fibromyalgia syndrome. We believe LDN may work via novel anti-inflammatory channels. The purpose of this study is to determine if LDN lowers inflammatory markers in individuals with fibromyalgia. |
NCT02897934 ↗ | CWI and Discharge After Breast Cancer Surgery | Completed | University College Cork | 2016-08-01 | The objectives of this work are threefold: 1. To evaluate the analgesic efficacy of CWI in women discharged within 23 hours of major breast cancer surgery 2. To evaluate objective indices of patient recovery following anaesthesia and surgery in a 23 hour model of care 3. To evaluate patient satisfaction with their care pathway | |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Android 10
Condition Name
Clinical Trial Locations for Android 10
Trials by Country
Clinical Trial Progress for Android 10
Clinical Trial Phase
Clinical Trial Sponsors for Android 10
Sponsor Name